Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2020

 

Politics in South Africa: ‘Post-COVID-19, Post-crisis’  

As a public higher-education institution in South Africa with a responsibility to contribute to public discourse, the University of the Free State (UFS) will be presenting the third UFS Thought-Leader Series in collaboration with Vrye Weekblad as part of the Vrystaat Literature Festival’s online initiative, VrySpraak-digitaal

This year, higher-education institutions globally are situated within a challenging context of COVID-19. Aware of, and grounded in the reality that the world will not return to the normality of pre-COVID-19, our responsibility as scholars still remains to contribute to public discourse and offer innovative solutions that will impact the lives of people nationally and globally to help them understand and adapt to a new world order. 

Against this background and context, this year’s debates focus on Post-COVID-19, Post-Crisis with Health and Modelling, the Economy, Politics and Predictions for 2021 as the sub-themes. Placed within a COVID-19 context and in lieu of the Free State Arts Festival, the series will be presented virtually in the form of one webinar per month from August 2020 to November 2020. 

Third webinar presented on 15 October 2020

The political landscape in South Africa was in a logjam before the COVID-19 pandemic, unable to deal decisively with the economic crisis. The worldwide COVID-19 crisis has aggravated an already dire situation. 

What should happen politically and economically to get South Africa on the path to recovery? And what are the prospects for the political landscape in South Africa post-COVID-19, post-crisis?
 
Date: 15 October 2020
Topic: Politics in South Africa: Post-COVID-19, Post-Crisis 
Time: 11:00-12:30

RSVP: Alicia Pienaar, pienaaran1@ufs.ac.za by 12 October 2020


Facilitator:

Editor: Vrye Weekblad 
Biography

Introduction and welcome:

Rector and Vice-Chancellor, UFS

Panellists:
Deputy Chairman of the South African Institute of International Affairs
(SAIIA)
Biography

Law Trust Chair in Social Justice, Stellenbosch University
Biography
 
Pro-Vice-Chancellor: Poverty, Inequality and Economic Development, UFS 
Biography

Chairman: Bidvest Group Limited, Chancellor of the UFS 
Biography

 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept